Carcinoma, Renal Cell: all 1,992 studies
Page 4 of 20. Open to participants first (387), then studies with results posted, then the rest; newest registration first within each.
- Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaRecruitingNCT05433142Phase 1
- A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid TumorsRecruitingNCT05420545Phase 1
- Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal CancerRecruitingNCT05420519Phase 1
- Decision Aid (DA) for Renal PatientsRecruitingNCT05387863Not applicable
- International REgistry of COnservative or Radical Treatment of Localized Kidney TumorsRecruitingNCT05363657
- Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More TreatmentRecruitingNCT05363280Phase 2
- Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC StudyRecruitingNCT05361720Phase 2
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruitingNCT05334069
- Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal CancerRecruitingNCT05329532Phase 1/2
- Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI TrialRecruitingNCT05327686Phase 2
- National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)RecruitingNCT05326620
- Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor ThrombusRecruitingNCT05319015Phase 2
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
- Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell CarcinomaRecruitingNCT05287945Phase 1/2
- International Multicentric Study ARON-1RecruitingNCT05287464
- Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney CancerRecruitingNCT05285579
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsRecruitingNCT05269381Phase 1/2
- Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerRecruitingNCT05267626Phase 1/2
- Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine TumorsRecruitingNCT05263050Phase 2
- Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)RecruitingNCT05259319Phase 1
- Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied PatientsNot yet recruitingNCT05241561Phase 2
- Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell CarcinomaRecruitingNCT05214885
- Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsRecruitingNCT05176483Phase 1
- Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell CarcinomaRecruitingNCT05155033Phase 2
- Autologous Dendritic Cell Vaccine in Kidney CancerRecruitingNCT05127824Phase 2
- Axitinib +/- Pembrolizumab in First Line Treatment of mPRCCRecruitingNCT05096390Phase 2
- Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxRecruitingNCT05092373Phase 1
- A Beta-only IL-2 ImmunoTherapY StudyRecruitingNCT05086692Phase 1/2
- Renal Cancer Detection With Liquid BiopsyRecruitingNCT05060783
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationRecruitingNCT05059444
- A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain MetastasesRecruitingNCT05048212Phase 2
- The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid TumorsRecruitingNCT05037825
- NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell CarcinomaRecruitingNCT05024318Phase 2
- Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid TumorsRecruitingNCT05024214Phase 1/2
- Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRTRecruitingNCT05023265Not applicable
- [18F]PT2385 PET/CT in Patients With Renal Cell CarcinomaRecruitingNCT04989959Phase 1
- Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney CancerRecruitingNCT04981509Phase 2
- Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell ManufacturingRecruitingNCT04981119
- GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid TumorsRecruitingNCT04977453Phase 1/2
- Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell CarcinomaRecruitingNCT04974671Phase 2
- Clinical Study of CAIX-targeted CAR-T Cells in the Treatment of Advanced Renal Cell CarcinomaRecruitingNCT04969354Phase 1
- TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural MesotheliomaRecruitingNCT04969315Phase 1/2
- A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell CancerNot yet recruitingNCT04958473Phase 2
- A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract MalignanciesRecruitingNCT04923178
- A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid TumorsRecruitingNCT04903873Phase 1/2
- A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsRecruitingNCT04895709Phase 1/2
- Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and RadiotherapyRecruitingNCT04892849
- Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney CancerRecruitingNCT04823923Not applicable
- Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition SyndromeRecruitingNCT04792463
- Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067RecruitingNCT04787042Phase 1/2
- Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsRecruitingNCT04777994Phase 1
- A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First LineRecruitingNCT04764487Phase 3
- Urine Omics Predicting IO Therapy Responses in mRCC PatientsRecruitingNCT04712305
- Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME TrialRecruitingNCT04693377Not applicable
- Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin ToxicityRecruitingNCT04631731Phase 1/2
- Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing MicrobiomeRecruitingNCT04625556
- An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or BiopsyRecruitingNCT04623502Not applicable
- Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab MonotherapyRecruitingNCT04605146Not applicable
- Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE TrialRecruitingNCT04510597Phase 3
- A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma MetastasesRecruitingNCT04299646Phase 2
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)RecruitingNCT04198766Phase 1/2
- Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNARecruitingNCT04197414
- Expression Levels of Nicotinamide Metabolism-related Protein (NMAP) in Newly Diagnosed Renal Cancer and Non-renal Cancer PopulationsRecruitingNCT04113486
- Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell CarcinomaRecruitingNCT04053855
- Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver NeoplasmsRecruitingNCT03981497
- A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other TumorsRecruitingNCT03972657Phase 1/2
- Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsRecruitingNCT03866382Phase 2
- Renal Cancer Detection Using Convolutional Neural NetworksRecruitingNCT03857373
- Pencil Beam Scanning in Patients With Renal TumorsRecruitingNCT03810651Early Phase 1
- Protocol Active Surveillance Small Renal Masses (SRMs)RecruitingNCT03804320Not applicable
- Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene MutationsRecruitingNCT03786796Phase 2
- MyVHL: Patient Natural History StudyRecruitingNCT03749980
- SABR for Renal TumorsRecruitingNCT03747133Not applicable
- WIRE - Novel Treatments in Renal Cell CancerRecruitingNCT03741426Phase 2
- A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)RecruitingNCT03592472Phase 3
- A Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsRecruitingNCT03475953Phase 1/2
- Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell CarcinomaRecruitingNCT03414827
- Registry Platform Urologic CancerRecruitingNCT03374267
- Renal Adjuvant MultiPle Arm Randomised TrialRecruitingNCT03288532Phase 3
- EUS-guided RFA for Solid Abdominal NeoplasmsRecruitingNCT03221335Not applicable
- Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid TumorRecruitingNCT03093688Phase 1/2
- Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing CancersRecruitingNCT02830724Phase 1/2
- A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant TreatmentNot yet recruitingNCT02688491Not applicable
- A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.RecruitingNCT02186925
- A Phase II Study of Cyberknife Radiosurgery for Renal Cell CarcinomaRecruitingNCT01890590Not applicable
- Use of Tracking Devices to Locate Abnormalities During Invasive ProceduresEnrolling by invitationNCT00102544Not applicable
- Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant DisordersRecruitingNCT00001238
- A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)Active, not recruitingNCT06099782Phase 2Results posted
- Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCCTerminatedNCT05846646Phase 2Results posted
- A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.CompletedNCT05745142Results posted
- NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursTerminatedNCT05714553Phase 1/2Results posted
- Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)Active, not recruitingNCT05696444Not applicableResults posted
- Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)CompletedNCT05650164Results posted
- Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).TerminatedNCT05534789Results posted
- A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.CompletedNCT05363072Results posted
- Study of PF-07263689 in Participants With Selected Advanced Solid TumorsTerminatedNCT05061537Phase 1Results posted
- Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)CompletedNCT05012865Results posted
- Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell CarcinomaTerminatedNCT04955743Phase 2Results posted
- An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)CompletedNCT04941768Results posted
- Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesTerminatedNCT04902040Phase 1/2Results posted